Skip to content

Clinical trials

Phase 1 Inflammation trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 1 Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20111
20172
20202
20211
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
AstraZeneca2
Queen Mary University of London2
Liminal BioSciences Ltd.1
Redx Pharma Ltd1
TME Pharma AG1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation12
Arthritis, Rheumatoid2
Fibrosis2
Anemia1
Blister1
Cardiovascular Diseases1
Chronic Disease1
Dermatitis1
Idiopathic Pulmonary Fibrosis1
Kidney Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.